Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Pomdoctor Limited (POM)

1.5100 -0.3000 (-16.57%)
As of 10:28:02 AM EST. Market Open.
Chart Range Bar
Loading chart for POM
  • Previous Close 1.8100
  • Open 1.6100
  • Bid --
  • Ask 1.0100 x 200
  • Day's Range 1.4900 - 1.6600
  • 52 Week Range 0.4330 - 103.5000
  • Volume 158,601
  • Avg. Volume 2,054,200
  • Market Cap (intraday) 4.198M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -40.3100
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.

www.7lk.com

165

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/9/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

POM
71.56%
S&P 500 (^GSPC)
9.77%

1-Year Return

POM
98.43%
S&P 500 (^GSPC)
11.68%

3-Year Return

POM
98.14%
S&P 500 (^GSPC)
72.85%

5-Year Return

POM
98.14%
S&P 500 (^GSPC)
60.39%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -90.16%

  • Return on Assets (ttm)

    -352.09%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    410.45M

  • Net Income Avi to Common (ttm)

    -370.07M

  • Diluted EPS (ttm)

    -40.3100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    12.61M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    4.1M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: